|
|
 |
| Primary Symbols & Exchanges: |
| AZN - London |
| AZN - New York Stock Exchange |
| ZEG - Frankfurt |
| AZN - Stockholm |
|
|
| Primary Industry: |
| Pharmaceutical |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activity is discovering, developing, manufacturing and marketing prescription pharmaceuticals, biologics and vaccines. The Group's operation focuses on six therapeutic areas namely, Cardiovascular, Gastrointestinal, Neuroscience, Oncology, Respiratory and Inflammation, and Infection. Products include Crestor, Atacand, Selok/Toprol-XL, Zestril, Nexium, Losec/Prilosec, Entocort, Seroquel, Diprivan, Naropin, Xylocaine, Arimidex, Faslodex, Zoladex, Iressa, Nolvadex, Abraxane, Symbicort, Pulmicort, Rhinocort, Accolate, Synagis and FluMist. The Group operates in the United Kingdom, Belgium, France, Germany, Italy, Spain, Sweden, the Netherlands, Canada, Puerto Rico, the United States of America, Australia and Japan. During 2007, the Group acquired the entire share capital of Medimmune Inc, Arrow Therapeutics Ltd and Atlantis Components Inc. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on AstraZeneca plc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
